Correlation with redox potentials and inhibitory effects on Epstein-Barr virus activation of azaanthraquinones

被引：18
|
作者：
Koyama, J [1 ]
Morita, I
Tagahara, K
Osakai, T
Hotta, H
Yang, MX
Mukainaka, T
Nishino, H
Tokuda, H
机构：
[1] Kobe Pharmaceut Univ, Higashinada Ku, Kobe, Hyogo 6588558, Japan
[2] Kobe Univ, Fac Sci, Dept Chem, Kobe, Hyogo 6578501, Japan
[3] Kyoto Prefectural Univ Med, Dept Biochem, Kyoto 6028566, Japan
来源：
CHEMICAL & PHARMACEUTICAL BULLETIN | 2001年 / 49卷 / 09期
关键词：
azaanthraquinone; Epstein-Barr virus activation; redox potential; cyclic voltammetry; anti-tumor promoting effect;
D O I：
10.1248/cpb.49.1214
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
means of cyclic voltammetry. A definite correlation has been found between the redox potentials and the inhibitory effects of the azaanthraquinones on Epstein-Barr virus early antigen (EBV-EA) activation. It has further been shown that the correlation can be made better by introducing an electronic property, i.e., the atomic charge at O-11 as an additional parameter.
引用
收藏
页码：1214 / 1216
页数：3
相关论文
共 50 条
  • [1] Correlation of redox potentials and inhibitory effects on Epstein-Barr virus activation of 2-azaanthraquinones
    Koyama, J
    Morita, I
    Kobayashi, N
    Osakai, T
    Hotta, H
    Takayasu, J
    Nishino, H
    Tokuda, H
    [J]. CANCER LETTERS, 2004, 212 (01) : 1 - 6
  • [2] Inhibitory effects on Epstein-Barr virus activation of anthraquinones: Correlation with redox potentials
    Koyama, J
    Tagahara, K
    Osakai, T
    Tsujino, Y
    Tsurumi, S
    Nishino, H
    Tokuda, H
    [J]. CANCER LETTERS, 1997, 115 (02) : 179 - 183
  • [3] Correlation between oxidation potentials and inhibitory effects on Epstein-Barr virus activation of flavonoids
    Koyama, Junko
    Morita, Izumi
    Kobayashi, Norihiro
    Konoshima, Takao
    Takasaki, Midori
    Osakai, Toshiyuki
    Tokuda, Harukuni
    [J]. CANCER LETTERS, 2008, 263 (01) : 61 - 66
  • [4] Correlation between reduction potentials and inhibitory effects on Epstein-Barr virus activation by emodin derivatives
    Koyama, Junko
    Inoue, Munetaka
    Morita, Izumi
    Kobayashi, Norihiro
    Osakai, Toshiyuki
    Nishino, Hoyoku
    Tokuda, Harukuni
    [J]. CANCER LETTERS, 2006, 241 (02) : 263 - 267
  • [5] Correlation between reduction potentials and inhibitory effects on Epstein-Barr virus activation of poly-substituted anthraquinones
    Koyama, J
    Morita, I
    Kobayashi, N
    Osakai, T
    Nishino, H
    Tokuda, H
    [J]. CANCER LETTERS, 2005, 225 (02) : 193 - 198
  • [6] Inhibitory effects of lapachol derivatives on Epstein-Barr virus activation
    Sacau, EP
    Estévez-Braun, A
    Ravelo, AG
    Ferro, EA
    Tokuda, H
    Mukainaka, T
    Nishino, H
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (04) : 483 - 488
  • [7] Inhibitory effects of anthraquinones and bianthraquinones on Epstein-Barr virus activation
    Koyama, J
    Morita, I
    Tagahara, K
    Ogata, M
    Mukainaka, T
    Tokuda, H
    Nishino, H
    [J]. CANCER LETTERS, 2001, 170 (01) : 15 - 18
  • [8] Correlation of redox potentials and inhibitory effects on Epstein-Baff virus activation of naphthoquinones
    Koyama, J
    Morita, I
    Kobayashi, N
    Osakai, T
    Hotta, H
    Takayasu, J
    Nishino, H
    Tokuda, H
    [J]. CANCER LETTERS, 2003, 201 (01) : 25 - 30
  • [9] Inhibitory effects of lantadenes and related triterpenoids on Epstein-Barr virus activation
    Inada, A
    Nakanishi, T
    Tokuda, H
    Nishina, H
    Iwashima, A
    Sharma, OP
    [J]. PLANTA MEDICA, 1995, 61 (06) : 558 - 559
  • [10] Correlation between reduction potentials and inhibitions of Epstein-Barr virus activation by anthraquinone derivatives
    Koyama, Junko
    Nisino, Yu
    Morita, Izumi
    Kobayashi, Norihiro
    Osakai, Toshiyuki
    Tokuda, Harukuni
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 4106 - 4109
12345